Use of preclinical models to identify markers of type 2 diabetes susceptibility and novel regulators of insulin secretion – A step towards precision medicine

BACKGROUND: Progression from pre-diabetes to type 2 diabetes (T2D) and from T2D to insulin requirement proceeds at very heterogenous rates among patient populations, and the risk of developing different types of secondary complications is also different between patients. The diagnosis of pre-diabete...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorens, Bernard, Rodriguez, Ana, Cruciani-Guglielmacci, Céline, Wigger, Leonore, Ibberson, Mark, Magnan, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768503/
https://www.ncbi.nlm.nih.gov/pubmed/31500826
http://dx.doi.org/10.1016/j.molmet.2019.06.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6768503/
https://www.ncbi.nlm.nih.gov/pubmed/31500826
http://dx.doi.org/10.1016/j.molmet.2019.06.008

Ejemplares similares